CA1213841A - Hybrid cell line for producing complement-fixing monoclonal antibody to mouse i-a antigen and to i-a analogous antigens on human and other animal lymphocytes, antibody and methods
- Google Patents
Hybrid cell line for producing complement-fixing monoclonal antibody to mouse i-a antigen and to i-a analogous antigens on human and other animal lymphocytes, antibody and methods
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan LtdfiledCriticalHoechst Japan Ltd
Application grantedgrantedCritical
Publication of CA1213841ApublicationCriticalpatent/CA1213841A/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
CA000429023A1982-05-281983-05-27Hybrid cell line for producing complement-fixing monoclonal antibody to mouse i-a antigen and to i-a analogous antigens on human and other animal lymphocytes, antibody and methods
ExpiredCA1213841A
(en)
Hybrid cell line for producing complement-fixing monoclonal antibody to mouse i-a antigen and to i-a analogous antigens on human and other animal lymphocytes, antibody and methods
Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Monoclonal antibodies for human tissue cross-matching, a diagnostic kit containing them, hybridomas for producing them and a method for producing the hybridomas
Establishment of stable mouse/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity
Hybrid cell line for producing complement-fixing monoclonal antibody to mouse i-a antigen and to i-a analogous antigens on human and other animal lymphocytes, antibody and methods
Analysis of a fetal calf serum-induced T cell line. I. H-2 restricted growth and expression of membrane-bound and released molecules bearing 5936-idiotypic determinants.
A new murine cell surface differentiation antigen (Leugp90) defined by a rat monoclonal antibody: cellular distribution and biochemical characterization.